marketinference27 分钟
Kymera Therapeutics Advances Oral Immunology Programs for 2025
Kymera Therapeutics, Inc. has outlined its key objectives for 2025, emphasizing its strategy to advance a portfolio of oral ...
来自MSN4 分钟
Kymera Provides Pipeline Objectives for 2025, Stock Gains
Kymera Therapeutics, Inc. KYMR announced its business goals for 2025, along with anticipated progress on its pipeline of ...